18F-AV-1451 positron emission tomography in Alzheimer's disease and progressive supranuclear palsy.
about
Multiparametric MRI to distinguish early onset Alzheimer's disease and behavioural variant of frontotemporal dementiaPET Tau and Amyloid-β Burden in Mild Alzheimer's Disease: Divergent Relationship with Age, Cognition, and Cerebrospinal Fluid BiomarkersClinical diagnosis of progressive supranuclear palsy: The movement disorder society criteria.Radiological biomarkers for diagnosis in PSP: Where are we and where do we need to be?Specific protein biomarker patterns for Alzheimer's disease: improved diagnostics in progress.Disease modification and Neuroprotection in neurodegenerative disorders.Imaging of glia activation in people with primary lateral sclerosis.Decreased N-Acetyl Aspartate/Myo-Inositol Ratio in the Posterior Cingulate Cortex Shown by Magnetic Resonance Spectroscopy May Be One of the Risk Markers of Preclinical Alzheimer's Disease: A 7-Year Follow-Up Study.Emerging Diagnostic and Therapeutic Strategies for Tauopathies.Pittsburgh Compound B and AV-1451 positron emission tomography assessment of molecular pathologies of Alzheimer's disease in progressive supranuclear palsy.New advances in tau imaging in parkinsonism.Tau burden and the functional connectome in Alzheimer's disease and progressive supranuclear palsy.Small-molecule PET Tracers for Imaging Proteinopathies.Tau Positron Emission Tomography Imaging in Degenerative Parkinsonisms.Tau-PET imaging with [18F]AV-1451 in primary progressive apraxia of speech.In vivo 18F-AV-1451 tau-PET signal in MAPT mutation carriers varies by expected tau isoforms.Neuroimaging in Dementia.A 2-Step Cerebrospinal Algorithm for the Selection of Frontotemporal Lobar Degeneration Subtypes.Imaging Aβ and tau in early stage Alzheimer's disease with [18F]AV45 and [18F]AV1451.Large inter- and intra-case variability of first generation tau PET ligand binding in neurodegenerative dementias.Imaging Protein Misfolding in the Brain Using β-Sheet LigandsPredict Disease Progression With Reaction Rate Equation Modeling of Multimodal MRI and PET[F]AV-1451 binding is increased in frontotemporal dementia due to C9orf72 expansionIn vivo coupling of tau pathology and cortical thinning in Alzheimer's diseaseDisease-related patterns of in vivo pathology in Corticobasal syndrome
P2860
Q33763640-B6F078FC-8039-4942-8A1A-7982976D5BD4Q38628805-C0B78A15-24A5-4032-935E-7A6EDE47D854Q38807324-511BE4AE-03CD-4FE4-99C2-75B7341BDF36Q39303669-0AD99523-5F2E-43D6-BCA6-305824109469Q42361526-BBD79F13-E9F1-4032-B73C-85522EBD341AQ42363882-97F07A27-A081-433C-BEFD-23B99C2B18BFQ44728742-13855879-23F8-4D41-A98B-0B39901ED1E1Q44937365-B09ACAEC-E960-463D-BAB9-D69C8B0B088BQ45870549-D12A7D02-568E-47D7-A460-2AEE0B0734C4Q47279644-E5FB9280-BA15-4518-A91B-17AE9DC107C6Q47329627-A290619F-57A3-4CB6-B80C-C9AA4243866BQ47886903-7F5EF69B-C8FF-4663-8334-940430F14ADCQ47926474-926E882A-C1D7-47ED-8CD8-0F1F01AC20BAQ49295547-2B5D57BA-B5DB-4387-9E54-642D7EA37216Q49900567-4A77D4CE-3CA6-4EC2-9E6C-E19E27412F31Q50026038-465770D3-A4BC-41D0-8B9E-1B619047C819Q51800676-A5FE967F-E088-4F17-B1A1-58BC5A7EE4E0Q53396502-F10584B6-247F-40FE-A7D6-EC952F3618DAQ54965551-DD66BA0D-3146-4158-9055-0DB287BED770Q55254017-E333A569-E94A-410A-8BA7-9C1C0D42F479Q57168250-13513F4F-F673-4688-97D4-EB8EEA24D827Q57817391-9008A3C7-237A-4C11-808F-C293FCBCCE42Q57822208-81065DD6-94DD-4E73-ABD1-6F7E516E2399Q58693324-FD952AE3-4C2F-4B63-837C-936367B2C206Q58794612-EA645130-8840-44B2-A77F-1BCCEF157ABE
P2860
18F-AV-1451 positron emission tomography in Alzheimer's disease and progressive supranuclear palsy.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 24 January 2017
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
18F-AV-1451 positron emission ...... rogressive supranuclear palsy.
@en
18F-AV-1451 positron emission ...... rogressive supranuclear palsy.
@nl
type
label
18F-AV-1451 positron emission ...... rogressive supranuclear palsy.
@en
18F-AV-1451 positron emission ...... rogressive supranuclear palsy.
@nl
prefLabel
18F-AV-1451 positron emission ...... rogressive supranuclear palsy.
@en
18F-AV-1451 positron emission ...... rogressive supranuclear palsy.
@nl
P2093
P2860
P50
P356
P1433
P1476
18F-AV-1451 positron emission ...... progressive supranuclear palsy
@en
P2093
Ajenthan Surendranathan
David Williamson
Elijah Mak
Franklin I Aigbirhio
John T O'Brien
Kieren S J Allinson
P Simon Jones
Patricia Vázquez Rodríguez
Robert Arnold
Robin J Borchert
P2860
P304
P356
10.1093/BRAIN/AWW340
P407
P577
2017-03-01T00:00:00Z